University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients

Completed

Conditions: Rheumatoid Arthritis

Interventions: Other: Musculoskeletal Ultrasound Imaging
Other: Synovial biopsy
Other: Biological samples collection
Other: Questionnaires

First Posted Date: 2015-06-19

Last Posted Date: 2022-05-20

Lead Sponsor: University of Oxford

Target Recruit Count: 43

Registration Number: NCT02476084

Locations: 🇬🇧
Nuffield Orthopaedic Centre, Oxford, United Kingdom

Fmri-based Neurofeedback With Anxious Adolescents Study

Phase 1

Conditions: Anxiety

Interventions: Behavioral: questionnaires
Device: Functional magnetic resonance imaging w neurofeedback

First Posted Date: 2015-06-04

Last Posted Date: 2016-11-10

Lead Sponsor: University of Oxford

Target Recruit Count: 50

Registration Number: NCT02463136

Locations: 🇬🇧
University of Oxford, Oxford, Oxfordshire, United Kingdom

Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern Myanmar

Phase 2

Withdrawn

Conditions: Artemisinin-resistant
Uncomplicated Falciparum Malaria

Interventions: Drug: Dihydroartemisinin-piperaquine phosphate (Duocotexin)
Drug: Arterolane maleate-piperaquine phosphate (Synriam)

First Posted Date: 2015-06-03

Last Posted Date: 2015-11-03

Lead Sponsor: University of Oxford

Registration Number: NCT02461186

PK Study of Anti-TB Drugs

Phase 1

Completed

Conditions: Tuberculosis

Interventions: Drug: Isoniazid (H)
Drug: Rifampicin (R)
Drug: Pyrazinamide (Z)
Drug: Ethambutol (E)

First Posted Date: 2015-05-29

Last Posted Date: 2018-10-03

Lead Sponsor: University of Oxford

Target Recruit Count: 61

Registration Number: NCT02457208

Locations: 🇹🇭
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand

A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC)

Phase 2

Completed

Conditions: Malaria, Falciparum

Interventions: Drug: ACT
Drug: TACT

First Posted Date: 2015-05-25

Last Posted Date: 2018-05-09

Lead Sponsor: University of Oxford

Target Recruit Count: 1110

Registration Number: NCT02453308

Locations: 🇧🇩
College of Medicine Chittagong, Ramu, Bangladesh
🇮🇳
Ispat General hospital, Rourkela, India
🇲🇲
Pyin oo Lwin hospital, Pyin oo Lwin, Myanmar

and more 17 locations

A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z

Phase 1

Conditions: Ebola Virus Disease

Interventions: Biological: MVA-EBO Z
Biological: ChAd3-EBO Z

First Posted Date: 2015-05-22

Last Posted Date: 2016-08-23

Lead Sponsor: University of Oxford

Target Recruit Count: 38

Registration Number: NCT02451891

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, Oxfordshire, United Kingdom

Improving Social Anxiety Symptoms (SocWell)

Not Applicable

Completed

Conditions: Wellbeing
Shyness

Interventions: Behavioral: E-Couch

First Posted Date: 2015-05-22

Last Posted Date: 2019-07-15

Lead Sponsor: University of Oxford

Target Recruit Count: 2105

Registration Number: NCT02451878

Locations: 🇦🇺
National Institute for Mental Health Research, Australian National University, Canberra, Australian Capital Territory, Australia
🇬🇧
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, Oxfordshire, United Kingdom

Severe and Cerebral Malaria Investigated Through Host Metabolomics

Completed

Conditions: Severe Malaria

Interventions: Other: Observation

First Posted Date: 2015-05-22

Last Posted Date: 2018-06-20

Lead Sponsor: University of Oxford

Target Recruit Count: 840

Registration Number: NCT02451904

Locations: 🇧🇩
Chittagong Medical College Hospital (CMCH), Chittagong, Bangladesh

A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS)

Phase 2

Terminated

Conditions: Osteosarcoma

Interventions: Drug: Mifamurtide
Drug: Ifosfamide

First Posted Date: 2015-05-12

Last Posted Date: 2019-09-13

Lead Sponsor: University of Oxford

Target Recruit Count: 8

Registration Number: NCT02441309

Locations: 🇬🇧
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
🇬🇧
University College London Hospitals NHS Foundation Trust, London, United Kingdom
🇳🇱
Department of Clinical Oncology, Leiden University Medical Center, Leiden, Postzone K1-P, Netherlands

and more 5 locations

Evaluating the Efficacy of Artesunate-mefloquine and the Relative Roles of Resistance Genetic Markers

Completed

Conditions: P. Falciparum Malaria
P. Falciparum Malaria Mixed Infection

First Posted Date: 2015-04-28

Last Posted Date: 2018-11-26

Lead Sponsor: University of Oxford

Target Recruit Count: 1022

Registration Number: NCT02427360

Locations: 🇹🇭
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy